Health Sciences Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Health Sciences Gr regular Real Value cannot be determined due to lack of data. The prevalent price of Health Sciences Gr is $0.0. Our model calculates the value of Health Sciences Gr from evaluating the firm fundamentals such as operating margin of (73.91) %, and Return On Asset of -0.73 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Health Sciences' price fluctuation is out of control at this time. Calculation of the real value of Health Sciences Gr is based on 3 months time horizon. Increasing Health Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Health pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Health Sciences Gr. Since Health Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Health Pink Sheet. However, Health Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The real value of Health Pink Sheet, also known as its intrinsic value, is the underlying worth of Health Sciences Gr Company, which is reflected in its stock price. It is based on Health Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Health Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Health Sciences Gr helps investors to forecast how Health pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Health Sciences more accurately as focusing exclusively on Health Sciences' fundamentals will not take into account other important factors: Health Sciences Total Value Analysis
Health Sciences Gr is currently projected to have valuation of 39.41 K with market capitalization of 281, debt of 407 K, and cash on hands of 1.71 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Health Sciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
39.41 K | 281 | 407 K | 1.71 K |
Health Sciences Investor Information
The company recorded a loss per share of 0.13. Health Sciences Gr had not issued any dividends in recent years. Based on the key indicators related to Health Sciences' liquidity, profitability, solvency, and operating efficiency, Health Sciences Gr is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Health Sciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Health Sciences has an asset utilization ratio of 34.75 percent. This implies that the Company is making $0.35 for each dollar of assets. An increasing asset utilization means that Health Sciences Gr is more efficient with each dollar of assets it utilizes for everyday operations.Health Sciences Profitability Analysis
The company reported the previous year's revenue of 358.43 K. Net Loss for the year was (54.49 K) with profit before overhead, payroll, taxes, and interest of 22.91 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Health Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Health Sciences and how it compares across the competition.
About Health Sciences Valuation
The pink sheet valuation mechanism determines Health Sciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Health Sciences. We calculate exposure to Health Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Health Sciences's related companies.Health Sciences Group Inc., through its subsidiaries, provides various products used in nutritional supplements and functional foods and beverages in the United States. Health Sciences Group was founded in 1996 as Centurion Properties Development Corporation and changed its name to iGoHealthy.com in 2000. Health Sciences is traded on OTC Exchange in the United States.
8 Steps to conduct Health Sciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Health Sciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Health Sciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Health Sciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Health Sciences' revenue streams: Identify Health Sciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Health Sciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Health Sciences' growth potential: Evaluate Health Sciences' management, business model, and growth potential.
- Determine Health Sciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Health Sciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Health Sciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Health Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -38.9 M |
Complementary Tools for Health Pink Sheet analysis
When running Health Sciences' price analysis, check to measure Health Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Sciences is operating at the current time. Most of Health Sciences' value examination focuses on studying past and present price action to predict the probability of Health Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Sciences' price. Additionally, you may evaluate how the addition of Health Sciences to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |